Keith D. Eaton - Concepedia

Author

Keith D. Eaton

Also Known As

Jayanta Debnath, K Eaton, K. D. Eaton, K. Eaton, K.D. Eaton, Keith D Eaton, Keith D. Eaton, Keith David Eaton, Keith Eaton, Kyle W Eaton

164

Publications

12.2K

Citations

H-Index

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center University of Washington Medical Center Seattle Cancer Care Alliance University of California San Diego

About

Keith D. Eaton is an author at University of Washington specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	957
2	Engineering	4	4	100
3	Health Sciences	2	2	43
4	Humanities	1	1	34
5	Applied Physics	1	1	17

Keith D. Eaton

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, New England Journal of Medicine	2012	7.9K
Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer Lecia V. Sequist, Benjamin Besse, Thomas J. Lynch, Journal of Clinical Oncology	2010	420
Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation Laurie L. Carr, David A. Mankoff, Bernardo Goulart, Clinical Cancer Research	2010	417
Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels Heather H. Cheng, Hye Son Yi, Yeon-Ju Kim, PLoS ONE	2013	304
Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Cancer Specimens Colin C. Pritchard, Stephen J. Salipante, Karen M. Koehler, Journal of Molecular Diagnostics	2013	276
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer Giuseppe Giaccone, Lyudmila Bazhenova, John Nemunaitis, European Journal of Cancer VaccinationTumor ImmunologyMedicineImmunologyMaintenance Therapy	2015	266
Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition Arnaud Augert, Emily Eastwood, Ali H. Ibrahim, Science Signaling	2019	221
Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial Renato Martins, Upendra Parvathaneni, Julie E. Bauman, Journal of Clinical Oncology	2013	201
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer Cristina P. Rodriguez, Qian Wu, Jenna Voutsinas, Clinical Cancer Research	2019	169
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN Laura Q.M. Chow, Chihiro Morishima, Keith D. Eaton, Clinical Cancer Research	2016	125

Page 1